Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Revista Médica La Paz
versión On-line ISSN 1726-8958
Resumen
AGUIRRE, Gunder et al. HEMATOLOGICAL ALTERATIONS IN COVID-19 PREGNANT WOMEN LIVING AT HIGH ALTITUDE. Rev. Méd. La Paz [online]. 2021, vol.27, n.1, pp.15-20. ISSN 1726-8958.
Introduction. COVID-19 pandemic has also affected pregnant women. Although at lower percentage, reports of serious maternal events as well as fetal compromise raise concern. Likewise, hematological conditions such as lymphopenia and eosinopenia in pregnant women with COVID-19, uncommon even in normal pregnant, have been reported. Objective. To characterize hematological alterations in full-term pregnant women with COVID-19, living at high altitude. Methods. It was conducted a retrospective descriptive longitudinal study that included 295 full-term pregnant women SARS-Cov-2 positives, hospitalized because of labor and delivery at Hospital de la Mujer in La Paz city (Bolivia) located at 3640 masl. Complete blood count, blood glucose, creatinine, total protein and clottin screening results were analyzed. Results. Average age was 28.5 years, and gestational age corresponded to 37.4 weeks. All pregnant women were classified with COVID-19 at Stage I. Laboratory studies showed averages of hemoglobin 13.0 g/dl, leukocytes 9825/ul and platelets 266 103 / ul; the clotting screening and the concentrations of glycemia, creatinine, total proteins and albumin were within normal parameters. 39% of the pregnant women had leukocytosis associated with neutrophilia and 1.4% had lymphopenia. Conclusions. Full-term pregnant women with COVID-19 at stage I in our context generally do not have lymphopenia; however, the presence ofsuch condition serves as a warning to take early action measures in case of COVID-19 complications in pregnant women. Probably, pregnancies at an early age and without underlying pathology are related to a less severe COVID-19.
Palabras clave : COVID-19; pregnancy; SARS-CoV-2; blood count.